Peptostreptococcus anaerobius is an anaerobic bacterium that normally lives in the human gut, mouth, and vaginal tract without causing harm, but it can trigger serious infections when it reaches sites outside its usual habitat or when the body’s defenses are compromised. It shows up in surgical wound infections, deep abscesses, necrotizing soft-tissue infections, and even rare cases of heart valve disease. Beyond these conventional infections, a surge of research over the past decade has placed P. anaerobius at the center of a more unsettling story: it appears to actively promote colorectal cancer.
Where It Lives and Who It Threatens
P. anaerobius is a strict anaerobe, meaning it grows only in the absence of oxygen. It colonizes oxygen-poor niches like the large intestine, the gingival crevices of the mouth, and the vaginal canal. In healthy people this colonization is uneventful. Trouble begins when the bacterium escapes those niches, often through a break in the intestinal wall during surgery, a perforated appendix, a deep wound, or a disrupted mucosal barrier.
A large study of peptostreptococcal infections in children found that about 40% had a predisposing condition. The most common were prior surgery, immune deficiency, cancer, trauma, diabetes, prematurity, steroid therapy, an implanted foreign body, and sickle-cell disease.1PubMed. Peptostreptococcal infection in children Adults share many of the same vulnerabilities. Diabetes deserves special mention because it creates multiple entry points: poor circulation damages skin and tissue, surgical debridements open new wounds, and impaired immune responses slow bacterial clearance.
Surgical Wounds, Abscesses, and Soft-Tissue Infections
In surgical settings, P. anaerobius is one of the most frequently recovered anaerobic cocci. A two-year study of anaerobic surgical infections found it was the most common anaerobic coccus isolated, appearing in about 14% of positive cultures. Necrotizing fasciitis was the single most common clinical presentation linked to anaerobic bacteria in that study, followed by deep-seated abscesses.2PubMed Central. Anaerobic infections in surgical wards: a two year study These infections are almost never caused by P. anaerobius alone. They are polymicrobial, with the bacterium appearing alongside organisms like Bacteroides fragilis, E. coli, and Klebsiella species.3The Brazilian Journal of Infectious Diseases. Surgical infections: a microbiological study
Diabetic foot ulcers are another common site. Multiple studies from different countries have recovered P. anaerobius from infected ulcers, usually as a secondary player behind Bacteroides species.4African Journal of Laboratory Medicine. Multicentre study of the burden of multidrug-resistant bacteria in the aetiology of infected diabetic foot ulcers Its presence in these wounds matters less for its individual virulence than for what it signals: a deep, oxygen-starved infection environment where anaerobes thrive, and where treatment choices need to cover organisms that many common antibiotics miss.
Endocarditis and Other Uncommon Infections
Although rare, P. anaerobius can infect heart valves. A review of reported cases found that all but one involved a prosthetic valve, and the aortic valve was affected in the majority. Five of six patients survived with appropriate antibiotic therapy, typically a beta-lactam for six weeks combined with an aminoglycoside for the first two weeks.5PubMed. Endocarditis due to Peptostreptococcus anaerobius: case report and literature review of peptostreptococcal endocarditis Embolic complications, which are a feared consequence of infective endocarditis, were confirmed in only one of those patients. The rarity of peptostreptococcal endocarditis means clinicians may not immediately suspect it, and the organism’s strict anaerobic growth requirements can delay identification in routine blood cultures.
Even more unusual is urinary tract infection caused by P. anaerobius. One documented case involved a 62-year-old man with a history of urological disease, whose urine sample yielded the organism when tested by modern identification methods.6Anaerobe. Peptostreptococcus anaerobius: Pathogenicity, identification, and antimicrobial susceptibility Urine is normally oxygenated enough to discourage strict anaerobes, so these cases tend to involve anatomic abnormalities or chronic urinary stasis that create pockets of low oxygen.
The Colorectal Cancer Connection
The most actively studied aspect of P. anaerobius is its relationship with colorectal cancer. Researchers comparing stool and mucosal samples from patients with colorectal cancer and healthy controls have consistently found that P. anaerobius is significantly more abundant in people with cancer.7Gastroenterology. Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice This alone doesn’t prove the bacterium causes cancer; it could simply prefer the tumor environment. But a series of laboratory and animal studies have moved the evidence well beyond mere association.
One mechanism involves the bacterium engaging two receptors on colon cells, TLR2 and TLR4, in a way that ramps up the production of reactive oxygen species inside the cells. That burst of oxidative stress triggers increased cholesterol production and, with it, faster cell growth. When the TLR2 or TLR4 pathways were blocked in experiments, or when an antioxidant was added, the bacterium could no longer drive cholesterol production or cell proliferation.8PubMed. Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice
A separate line of research identified a surface protein on P. anaerobius, called PCWBR2, that latches directly onto a receptor called integrin α2/β1 on colon cells. That receptor is frequently overexpressed in colorectal tumors, essentially giving the bacterium a preferred docking site on cancerous tissue. Once PCWBR2 binds the integrin, it switches on a signaling cascade that promotes cell growth and activates inflammatory responses inside the cell.9PubMed. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity More recently, another surface protein called NlpC/P60 was found to interact with a different receptor on cancer stem cells, potentially promoting both cancer stemness and resistance to chemotherapy drugs.10Cancer Research. Abstract LB154: Peptostreptococcus anaerobius induces colorectal cancer stemness and chemoresistance via its surface protein NIpC/P60 interacting with Annexin A2 to activate YAP/Hippo signaling pathway
What this body of work suggests is that P. anaerobius isn’t just a passive bystander in colorectal tumors. It appears to actively push colon cells toward cancerous behavior through multiple independent mechanisms, and it may help existing tumors resist treatment. Researchers have not yet established that eliminating the bacterium prevents or slows cancer in humans, but the mechanistic evidence is strong enough that it has become a focus for microbiome-targeted cancer research.
Fueling Gut Inflammation
The cancer story is closely related to, but distinct from, another set of findings about gut inflammation. In a mouse model of colitis, animals that were fed P. anaerobius experienced greater weight loss and more severe disease compared to controls. The bacterium activated an inflammatory pathway in immune cells called macrophages, driving them toward a form of inflammatory cell death. It also disrupted the gut’s protective barrier and contributed to microbial imbalance during the course of the disease.11PubMed Central. Peptostreptococcus anaerobius enhances dextran sulfate sodium-induced colitis by promoting nf-κB-NLRP3-Dependent macrophage pyroptosis These findings raise the possibility that P. anaerobius overgrowth could worsen inflammatory bowel conditions in humans, though direct clinical evidence for this is still limited. The inflammatory pathways it activates in colitis overlap with those implicated in cancer promotion, which may help explain why chronic gut inflammation and colorectal cancer risk tend to travel together.
How It Is Identified in the Lab
Diagnosing an infection caused by a strict anaerobe is harder than diagnosing one caused by common aerobic bacteria. P. anaerobius grows slowly, requires specialized oxygen-free culture conditions, and can be killed by even brief exposure to air during sample transport. If a clinical specimen isn’t handled under anaerobic conditions from the moment it’s collected, the organism may never grow in the lab at all. This is one reason anaerobic infections in general are underdiagnosed.
A technology that has transformed anaerobic identification is MALDI-TOF mass spectrometry, which identifies bacteria by their protein signature rather than by waiting for them to grow through a series of biochemical tests. Evaluations of this technology have shown it to be both reliable and efficient for anaerobic species, requiring very little bacterial material.12PubMed Central. Decoding anaerobes: a comprehensive evaluation of MALDI-TOF Sirius and VITEK MS PRIME in clinical settings In at least one reported case, MALDI-TOF was able to identify P. anaerobius directly from a urine sample without the need for prior culture, cutting the time to diagnosis substantially.6Anaerobe. Peptostreptococcus anaerobius: Pathogenicity, identification, and antimicrobial susceptibility Genetic sequencing of the bacterial 16S ribosomal RNA gene provides a definitive identification when other methods give ambiguous results, though it is slower and more expensive than mass spectrometry.
Treatment and Antibiotic Resistance
For most clinical infections involving P. anaerobius, the antibiotic options are reassuringly broad. A susceptibility study of clinical isolates found that none of the tested strains were resistant to metronidazole, penicillin, cefoxitin, or chloramphenicol.13Journal of Pure and Applied Microbiology. Antimicrobial Susceptibility Profile of Clinical Isolates of Peptostreptococcus anaerobius Metronidazole and penicillin are the most commonly used first-line agents. Metronidazole is particularly well suited because it selectively targets anaerobic bacteria while sparing most aerobic flora.
Clindamycin is a different story. The same study found resistance in over half of the isolates tested.13Journal of Pure and Applied Microbiology. Antimicrobial Susceptibility Profile of Clinical Isolates of Peptostreptococcus anaerobius This is clinically significant because clindamycin is often chosen empirically for mixed anaerobic infections, especially skin and soft-tissue infections. If P. anaerobius is suspected or confirmed, switching to metronidazole or a beta-lactam is the safer bet. For endocarditis, the published cases describe prolonged courses of a beta-lactam antibiotic, typically for six weeks, sometimes combined with an aminoglycoside during the initial phase.5PubMed. Endocarditis due to Peptostreptococcus anaerobius: case report and literature review of peptostreptococcal endocarditis
Because P. anaerobius infections are almost always polymicrobial, treatment in practice means covering the full range of co-infecting organisms. A deep abdominal abscess, for example, might require a combination that covers anaerobes like Bacteroides, gram-negative aerobes like E. coli, and gram-positive cocci. Surgeons also rely heavily on source control: draining abscesses, debriding dead tissue, and removing infected prosthetic material when possible. Antibiotics alone rarely resolve deep-seated anaerobic infections without adequate surgical intervention.
Biofilms and Why Some Infections Resist Treatment
One reason anaerobic infections can be stubborn involves biofilms, the structured communities of bacteria that adhere to surfaces and encase themselves in a protective matrix. P. anaerobius participates in polymicrobial biofilms, and its presence can change the behavior of the entire community. In a study of biofilms relevant to bacterial vaginosis, researchers grew triple-species biofilms containing Gardnerella vaginalis, Fannyhessea vaginae, and P. anaerobius. Neither metronidazole nor clindamycin could reduce the total biomass of these triple-species biofilms, even though G. vaginalis was highly susceptible to clindamycin when tested on its own.14Journal of Antimicrobial Chemotherapy. In vitro interactions within a biofilm containing three species found in bacterial vaginosis (BV) support the higher antimicrobial tolerance associated with BV recurrence
This finding helps explain a frustrating clinical pattern: infections that respond initially to antibiotics but keep coming back. The biofilm acts as a physical shield and also seems to create a cooperative metabolic environment in which the participating species protect each other from drugs. For recurrent infections where P. anaerobius is involved, disrupting the biofilm mechanically through debridement or irrigation may be just as important as choosing the right antibiotic.
Stool-Based Cancer Screening and Biomarker Potential
The consistent enrichment of P. anaerobius in the stool and mucosal tissue of colorectal cancer patients has opened up an intriguing diagnostic angle. Researchers are exploring whether bacterial signatures in stool samples could serve as early warning signals for colorectal cancer, potentially complementing or even rivaling existing screening tests. A review of gut microbiome-based biomarker approaches found that bacterial signatures including P. anaerobius, Fusobacterium nucleatum, and Parvimonas micra achieved strong diagnostic accuracy for early-stage colorectal cancer identification.15PubMed Central. Noninvasive early detection of colorectal cancer through gut microbiome-derived biomarkers
The appeal of a stool-based microbial test is obvious: it’s non-invasive, it doesn’t require bowel preparation, and it could be repeated at regular intervals without the cost or discomfort of colonoscopy. Current stool-based tests look for blood or shed DNA from tumor cells. Adding a microbial layer could improve sensitivity, particularly for early-stage cancers that shed fewer detectable cells. The technology is still in research phases, and no validated clinical test based on P. anaerobius levels alone exists yet. But the combination of multiple bacterial markers has shown enough promise that several groups are working toward clinical validation.
An Unusual Metabolic Quirk
One detail that sets P. anaerobius apart from many bacteria is its dependence on the amino acid proline. Under anaerobic conditions, the organism cannot metabolize glucose or other amino acids unless proline is present. Proline acts as a kind of metabolic ignition key: without it, cells sit idle even when surrounded by glucose. During the breakdown of other amino acids, the bacterium simultaneously converts proline into a ring-cleavage product, using it as an electron sink to keep its energy-generating chemistry running.16Infection and Immunity. Proline requirement for glucose utilization by Peptostreptococcus anaerobius ATCC 27337 This dependency is more than a biochemical curiosity. The tumor microenvironment tends to be rich in amino acids including proline, which may help explain why P. anaerobius thrives so well in and around colorectal tumors. Whether targeting proline availability could starve the bacterium in a therapeutic context is speculative, but it represents the kind of metabolic vulnerability that researchers are beginning to explore.